Expert Ratings for Amgen
Portfolio Pulse from Benzinga Insights
In the last quarter, Amgen (NASDAQ:AMGN) received 3 bullish, 2 somewhat bullish, and 4 indifferent ratings from analysts. Over the past 3 months, 9 analysts have offered 12-month price targets for Amgen, with an average price target of $278.44, a high of $320.00, and a low of $223.00. The average price target has increased by 8.85% over the past month.
October 11, 2023 | 4:00 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Amgen has received a mix of bullish and indifferent ratings from analysts, with an increasing average price target. This could indicate a positive outlook for the company's stock.
Analyst ratings and price targets can significantly influence investor sentiment and stock prices. The increasing average price target and the majority of bullish or indifferent ratings suggest a positive outlook for Amgen's stock in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100